Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

This therapy effectively treats resistant alopecia areata with minimal side effects.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

BST2 is a key marker for hair loss disease alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Trichohyalin may trigger the immune response causing alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

DPCP is effective for treating severe alopecia areata, but relapse is common.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Certain cytokines and growth factors can stop hair growth and may play a role in alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

PRP treatment may help with alopecia areata, especially in newer cases.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Candida antigen is an effective and promising treatment for alopecia areata.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.